CompletedNot Applicable

CETIS-I (CEra Traction Improves Spine-I)

South Korea60 participantsStarted 2023-01-03

Plain-language summary

In this clinical trial, equivalence is evaluated by exploratory comparison of changes in X-Ray lesions with test group (Cerazem Master V6) and control group (physical therapy) in patients with intervertebral disc herniation and degenerative stenosis.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subject who has been diagnosed with intervertebral disc herniation or degenerative stenosis (a person who has been diagnosed in the past or has been diagnosed upon obtaining consent) * Adult men and women over 19 years of age * Body mass index (BMI) 18.5 over to less than 30 Exclusion Criteria: * Subject with fibromyalgia, dystonia, and epilepsy * Subject with sensory impairment * Subject with physical irritation-induced skin lesions such as fever and compression (dermatosis, compression urticaria, choline urticaria, fever urticaria, etc.)

What they're measuring

Anterior and posterior distance changes of L2-S1 intervertebral disc

Timeframe: Immediately after application

Trial details

NCT IDNCT05549596

SponsorCeragem Clinical Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-05-22

View on ClinicalTrials.gov More Lumbar Disc Herniation trials